Safe, Effective, Affordable
Ketamine therapy offers a rapid turnaround effect on employee health. The therapy is clinically-documented to improve mental health symptoms for 70% of treatment-resistant individuals. Endorsed by leading medical institutions such as Mass General, Mayo Clinic, and the National Network of Depression Centers.
Ketamine is an FDA-approved medication that is commonly used as a general anesthetic in medical procedures. Doctors may also prescribe lower doses of IV-ketamine for off-label uses such as treatment-resistant depression and other mental health conditions. Many FDA-approved medications, including ketamine, have well-documented off-label uses
In 2023, The New England Journal of Medicine (NEJM) published data providing evidence that IV-ketamine therapy for treatment-resistant depression is clinically superior to other treatments.
IV Ketamine is a proven, low-cost, generic treatment for mental health conditions—especially treatment-resistant depression. By offering employees access to TARA Mind’s evidence-based care, employers promote health equity and remove cost barriers to effective treatment.
